NCT03535948Unknown不适用
Outcome of Hodgkin Lymphoma Patients Over Than 60 Years Treated by Chemotherapy and/or Radiotherapy: a Retrospective Study
Central Hospital, Nancy, France2 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2018年5月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 90
- 试验地点
- 2
- 主要终点
- Progression-free survival
研究概览
简要总结
Outcome of Hodgkin lymphoma patients over than 60 years treated by chemotherapy and/or radiotherapy: retrospective analysis.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 60 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients over than 60 years
- •Newly diagnosed Hodgkin lymphoma
排除标准
- •Data not available
结局指标
主要结局
Progression-free survival
时间窗: Time between diagnosis and progression or death - up to 100 weeks
From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Hodgkin Lymphoma (HL).Hodgkin LymphomaNCT00301314Royal Marsden NHS Foundation Trust
已完成
不适用
Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's LymphomaLong-term Effects Secondary to Cancer Therapy in ChildrenLymphomaNCT00091091Children's Oncology Group530
已完成
不适用
Kinetic of Cytokines Decrease and Hodgkin Lymphoma PrognosticHodgkin's DiseaseNCT01833884Centre Henri Becquerel50
已完成
2 期
Bendamustine Study in Classical Hodgkin Lymphoma Patients Over 60 Treated by Prednisone, Vinblastine and DoxorubicinClassical Hodgkin LymphomaNCT02414568The Lymphoma Academic Research Organisation90
已完成
4 期
Doxorubicin Pharmacokinetics and Response in Non Hodgkin's LymphomaNon-Hodgkin's LymphomaNCT00969462Meir Medical Center18